Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Journal of Neuro-Oncology|April 21, 2015
Microenvironment involved in FPR1 expression by human glioblastomasJ C Boer, D M S van Marion, J V Joseph, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 2007
Chemotherapy response evaluation with 18F-FDG PET in patients with non-small cell lung cancerLioe-Fee de Geus-Oei, Henricus F M van der Heijden, Eric P Visser, et al.
British Journal of Cancer|January 17, 2013
Inhibition of formyl peptide receptor in high-grade astrocytoma by CHemotaxis Inhibitory Protein of S. aureusJ C Boer, U M Domanska, H Timmer-Bosscha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
Phase I clinical and magnetic resonance imaging study of the vascular agent NGR-hTNF in patients with advanced cancers (European Organization for Research and Treatment of Cancer Study 16041)Hanneke W M van Laarhoven, Walter Fiedler, Ingrid M E Desar, et al.
American Journal of Obstetrics and Gynecology|June 18, 2025
Impact of breast cancer history on decision-making for ovarian cancer risk-reducing surgery in the TUBA-WISP-II studyTamar A Gootzen, Miranda P Steenbeek, Marleen M H J van Gelder, et al.
Genes|May 19, 2018
Conventional Pathology Versus Gene Signatures for Assessing Luminal A and B Type Breast Cancers: Results of a Prospective Cohort StudyJulia E C van Steenhoven, Anne Kuijer, Paul J van Diest, et al.
Nature|April 15, 2026
Prospective evaluation of genomics-guided off-label treatmentK Verkerk, A C Spiekman, S F Haj Mohammad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
The first-in-human study of the hydrogen sulfate (Hyd-sulfate) capsule of the MEK1/2 inhibitor AZD6244 (ARRY-142886): a phase I open-label multicenter trial in patients with advanced cancerUdai Banerji, D Ross Camidge, Henk M W Verheul, et al.
Breast Cancer Research and Treatment|October 25, 2018
Body composition is associated with risk of toxicity-induced modifications of treatment in women with stage I-IIIB breast cancer receiving chemotherapyMaaike M G A van den Berg, Dieuwertje E Kok, Liesbeth Posthuma, et al.
Breast Cancer Research and Treatment|September 30, 2024
70-Gene signature-guided adjuvant systemic treatment adjustments in early-stage ER+ breast cancer patients: 7-year follow-up of a prospective multicenter cohort studyEline E F Verreck, Anne Kuijer, Julia E C van Steenhoven, et al.
Pageof 8